| Lantheus Holdings, Inc | $6.6b | $100.68 | -0.0% | 54.6K | |
| AbCellera Biologics Inc. Common Shares | $3.7b | $11.40 | -1.1% | 862.7K | |
| Immunome, Inc. | $3.1b | $23.95 | +0.8% | 185.7K | |
| Aktis Oncology, Inc. Common stock | $1.5b | $22.09 | -1.8% | 54.7K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.3b | $14.98 | -0.5% | 92.3K | |
| Crescent Biopharma, Inc. Common Stock | $0.7b | $18.79 | -0.2% | 23.0K | |
| Perspective Therapeutics, Inc. | $353.9m | $2.67 | -2.6% | 232.1K | |
| Actinium Pharmaceuticals, Inc | $31.4m | $1.26 | +0.8% | 6.8K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $30.1m | $3.91 | 0.0% | N/A | |
| American Shared Hospital Services | $9.6m | $1.45 | +5.6% | 1.8K | |
| iTonic Holdings Ltd Class A Ordinary Shares | $5.1m | $0.30 | 0.0% | 59.6K |